JAN 21, 2017 9:00 AM PST

3D Printed Vessels Successfully Implanted into Monkeys

WRITTEN BY: Xuan Pham

A Chinese company recently laid claim to being the first to successfully implant 3D, synthetically printed blood vessels into monkeys. Such breakthrough is predicted to pave the way for more 3D printed therapies for patients with cardiovascular diseases in the future. Furthermore, scientists hope the success of these synthetic blood vessels will provide a key puzzle piece in the development of 3D printed organs.

Located in the Sichuan capital of Chengdu, an up-and-coming hub for many start-ups, Sichuan Revotek is convinced of the potential of 3D printing in biomedicine. Last year, the company developed “the world's first 3D blood vessel bio-printer” for the purpose of producing “personalized functional organs.” This year, they’ve applied the technology to produce blood vessels that can survive after transplantation into an animal.

Sichuan Revotek credits the recent success to their patented type of bio-ink, known as “Biosynsphere.” This “ink” mixture consists of stems cells that came from the monkey’s fat tissues. In addition, the mix has a proprietary blend of growth factors and nutrients that not only keep the stem cells alive, but promote growth and attachment of these cells to the animal’s biological structures. Because the stem cells came from the monkeys’ own fat cells, the risk of rejection is lower.

In experiments, Chinese scientists implanted a 2-centimeter 3D-printed blood vessel in the abdominal artery of 30 rhesus monkeys. Within 5 days, the stem cells had differentiated into endothelial cells and smooth muscle cells, which are characteristic cells found in healthy, functioning blood vessels.

Over the course of a month, the progress was even more remarkable, as the scientists reported the integration of the 3D vessels with the monkeys’ own arteries.

This study is "the first to have maintained the viability of the cells with the 3-D printing technology," said James Kang, chief scientist and CEO of Sichuan Revotek. "And the bio-ink's capacity to develop collagen, a necessity for the tissue to mold into different shapes, is the first of its kind," he added.

Bolstered by their success, the company is seeking approval for testing in human clinical trials. “The tissues we implanted will have mingled with the original ones and grown into a regular vessel,” said researcher Kang Yujian. “This is unprecedented.”

But while other experts are also impressed with this innovation, some caution that more time is necessary to understand the stability of these 3D printed vessels. And this may take years to know. Nevertheless, Sichuan Revotek’s achievement represents an important step in 3D printed biomedicine.

Additional sources: CNN, 3DPrint, Xinhua News

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 14, 2020
Health & Medicine
Direct Amplification: Rapid, Extraction-Free RT-qPCR Results
SEP 14, 2020
Direct Amplification: Rapid, Extraction-Free RT-qPCR Results
As the SARS-CoV-2 pandemic continues to rage across the United States and around the globe, the demand for COVID-19 test ...
NOV 05, 2020
Clinical & Molecular DX
Digging DEEP into Metabolomic Space
NOV 05, 2020
Digging DEEP into Metabolomic Space
Metabolomics is an umbrella term encompassing lipidomics and the study of smaller polar metabolites.  As such, more ...
NOV 05, 2020
Clinical & Molecular DX
Painless Microneedle Patch Diagnoses Malaria in Minutes
NOV 05, 2020
Painless Microneedle Patch Diagnoses Malaria in Minutes
It looks like a Band-Aid — a small, adhesive patch that is applied directly to the skin. This simple, low-cost dia ...
NOV 12, 2020
Clinical & Molecular DX
Study Shows 1 in 5 COVID Tests Are False Positives
NOV 12, 2020
Study Shows 1 in 5 COVID Tests Are False Positives
  A study published in The BMJ has brought to light that the rapid finger-prick COVID-19 test may not be quite as r ...
NOV 16, 2020
Clinical & Molecular DX
How the CRISPR-based COVID Microlab Can Intercept the Pandemic
NOV 16, 2020
How the CRISPR-based COVID Microlab Can Intercept the Pandemic
The demand for diagnostic technologies to track COVID-19 infections and control community spread of the disease has only ...
DEC 26, 2020
Clinical & Molecular DX
Navigating the Genomic Landscape of Cancer in Asians
DEC 26, 2020
Navigating the Genomic Landscape of Cancer in Asians
Precision medicine — a clinical paradigm that tailors treatments specifically to patients based on their genetic a ...
Loading Comments...